267
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Targeting Chromatin in Fungal Pathogens as A Novel Therapeutic Strategy: Histone Modification Gets Infectious

, &
Pages 129-132 | Published online: 20 Apr 2011

Bibliography

  • Kouzarides T : Chromatin modifications and their function.Cell128(4) , 693–705 (2007).
  • Jenuwein T , AllisCD: Translating the histone code.Science293(5532) , 1074–1080 (2001).
  • Smith E , ShilatifardA: The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes.Mol. Cell40(5) , 689–701 (2010).
  • Lopez-Rubio JJ , RiviereL, ScherfA: Shared epigenetic mechanisms control virulence factors in protozoan parasites.Curr. Opin. Microbiol.10(6) , 560–568 (2007).
  • Agbor-Enoh S , SeudieuC, DavidsonE, DritschiloA, JungM: Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.Antimicrob. Agents Chemother.53(5) , 1727–1734 (2009).
  • Van De Veerdonk FL , KullbergBJ, NeteaMG: Pathogenesis of invasive candidiasis.Curr. Opin. Crit. Care16(5) , 453–459 (2010).
  • Pfaller MA , DiekemaDJ: Epidemiology of invasive candidiasis: a persistent public health problem.Clin. Microbiol. Rev.20(1) , 133–163 (2007).
  • Cowen LE : The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.Nat. Rev. Microbiol.6(3) , 187–198 (2008).
  • Ferwerda G , NeteaMG, JoostenLA, Van Der Meer JW, Romani L, Kullberg BJ: The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine28(3) , 614–622 (2010).
  • Simonetti G , PassarielloC, RotiliD, MaiA, GaraciE, PalamaraAT: Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.FEMS Yeast Res.7(8) , 1371–1380 (2007).
  • Smith WL , EdlindTD: Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.Antimicrob. Agents Chemother.46(11) , 3532–3539 (2002).
  • Pfaller MA , MesserSA, GeorgopapadakouN, MartellLA, BestermanJM, DiekemaDJ: Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.J. Clin. Microbiol.47(12) , 3797–3804 (2009).
  • Hnisz D , MajerO, FrohnerIE, KomnenovicV, KuchlerK: The Set3/Hos2 histone deacetylase complex attenuates cAMP/PKA signaling to regulate morphogenesis and virulence of Candida albicans.PLoS Pathog.6(5) , e1000889 (2010).
  • Lopes Da Rosa J , BoyartchukVL, ZhuLJ, KaufmanPD: Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis.Proc. Natl Acad. Sci. USA107(4) , 1594–1599 (2009).
  • Wurtele H , TsaoS, LepineGet al.: Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy.Nat. Med.16(7) , 774–780 (2010).
  • Kottom TJ , HanJ, ZhangZ, LimperAH: Pneumocystis carinii expresses an active Rtt109 histone acetyltransferase.Am. J. Respir. Cell Mol. Biol. doi:10.1165/rcmb.2009–0443OC (2010) (Epub ahead of print).
  • Hnisz D , SchwarzmüllerT, KuchlerK: Transcriptional loops meet chromatin: a dual-layer network controls white-opaque switching in Candida albicans.Mol. Microbiol.74(1) , 1–15 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.